| Changes in muscle strength, relaxation rate and fatiguability during the human menstrual cycle R Sawar, B Beltran-Niclos, O Rutherford Journal of Physiology 493, 267-272, 1996 | 510 | 1996 |
| The effect of nitric oxide on cell respiration: A key to understanding its role in cell survival or death B Beltrán, A Mathur, MR Duchen, JD Erusalimsky, S Moncada Proceedings of the National Academy of Sciences 97 (26), 14602-14607, 2000 | 479 | 2000 |
| Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease MJ Casanova, M Chaparro, E Domenech, M Barreiro-de Acosta, ... Official journal of the American College of Gastroenterology| ACG 108 (3 …, 2013 | 262 | 2013 |
| Oxidative stress and S‐nitrosylation of proteins in cells B Beltrán, A Orsi, E Clementi, S Moncada British journal of pharmacology 129 (5), 953-960, 2000 | 235 | 2000 |
| Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for neuroprotection/neurodegeneration? ME Gegg, B Beltran, S Salas‐Pino, JP Bolanos, JB Clark, S Moncada, ... Journal of neurochemistry 86 (1), 228-237, 2003 | 213 | 2003 |
| Evaluation of postsurgical recurrence in Crohn's disease: a new indication for capsule endoscopy? VP Beltrán, P Nos, G Bastida, B Beltrán, L Argüello, M Aguas, A Rubín, ... Gastrointestinal Endoscopy 66 (3), 533-540, 2007 | 190 | 2007 |
| Ulcerative colitis in smokers, non-smokers and ex-smokers G Bastida, B Beltrán World journal of gastroenterology: WJG 17 (22), 2740, 2011 | 167 | 2011 |
| Inhibition of mitochondrial respiration by endogenous nitric oxide: a critical step in Fas signaling B Beltrán, M Quintero, E García-Zaragozá, E O'Connor, JV Esplugues, ... Proceedings of the National Academy of Sciences 99 (13), 8892-8897, 2002 | 161 | 2002 |
| Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease M Iborra, F Bernuzzi, C Correale, S Vetrano, G Fiorino, B Beltrán, ... Clinical & Experimental Immunology 173 (2), 250-258, 2013 | 156 | 2013 |
| Incidence, risk factors and clinical course of thiopurine‐induced liver injury in patients with inflammatory bowel disease G Bastida, P Nos, M Aguas, B Beltrán, A Rubín, F Dasí, J Ponce Alimentary pharmacology & therapeutics 22 (9), 775-782, 2005 | 147 | 2005 |
| Role of oxidative stress and antioxidant enzymes in Crohn's disease M Iborra, I Moret, F Rausell, G Bastida, M Aguas, E Cerrillo, P Nos, ... Biochemical Society Transactions 39 (4), 1102-1106, 2011 | 145 | 2011 |
| Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naive and treated Crohn's disease B Beltran, P Nos, F Dasí, M Iborra, G Bastida, M Martínez, JE O'Connor, ... Inflammatory bowel diseases 16 (1), 76-86, 2010 | 142 | 2010 |
| Study of the viral and microbial communities associated with Crohn's disease: a metagenomic approach V Pérez-Brocal, R García-López, JF Vázquez-Castellanos, P Nos, ... Clinical and translational gastroenterology 4 (6), e36, 2013 | 131 | 2013 |
| Assessing an improved protocol for plasma microRNA extraction I Moret, D Sanchez-Izquierdo, M Iborra, L Tortosa, A Navarro-Puche, ... PloS one 8 (12), e82753, 2013 | 129 | 2013 |
| Prevalence of gastro‐oesophageal reflux disease in Spain and associated factors J Ponce, O Vegazo, B Beltrán, J Jiménez, J Zapardiel, D Calle, JM Pique, ... Alimentary pharmacology & therapeutics 23 (1), 175-184, 2006 | 128 | 2006 |
| Evolution after anti-TNF discontinuation in patients with inflammatory bowel disease: a multicenter long-term follow-up study MJ Casanova, M Chaparro, V García-Sánchez, O Nantes, E Leo, ... Official journal of the American College of Gastroenterology| ACG 112 (1 …, 2017 | 121 | 2017 |
| Epidemiological risk factors in microscopic colitis: a prospective case–control study F Fernández-Bañares, MR de Sousa, A Salas, B Beltrán, M Piqueras, ... Inflammatory bowel diseases 19 (2), 411-417, 2013 | 119 | 2013 |
| Smoking does influence disease behaviour and impacts the need for therapy in Crohn′ s disease in the biologic era T Nunes, MJ Etchevers, E Domènech, V García‐Sánchez, Y Ber, ... Alimentary pharmacology & therapeutics 38 (7), 752-760, 2013 | 111 | 2013 |
| Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients M Aguas, G Bastida, E Cerrillo, B Beltrán, M Iborra, C Sánchez-Montes, ... World Journal of Gastroenterology: WJG 18 (32), 4391, 2012 | 102 | 2012 |
| Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect M Iborra, B Beltrán, G Bastida, M Aguas, P Nos Journal of Crohn's and Colitis 5 (2), 157-161, 2011 | 94 | 2011 |
